Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...
31 Million Americans Use GLP‑1s, but New Claims Suggest They Aren’t Being Warned About Serious Risks
About 12 percent of Americans—more than 31 million people—are currently using GLP-1 medications, according to estimates from the nonpartisan health policy group KFF. The drugs mimic a hormone that ...
A flurry of posts from the White House, Department of Labor and Department of Homeland Security have included images, slogans and even a song used by the white nationalist right. A flurry of posts ...
GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results